FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

6 letters match. Newest first.

  1. Walgreen Company

    FDA warns Walgreen Company that its Walgreens Sensitive Extra Whitening drug listing is incomplete and inaccurate.

    Low
  2. Lydia Co. Ltd.

    Lydia Co. Ltd. submitted mismatched drug listing data for eight products, leading FDA to remove them from its NDC Directory.

    Low
  3. Procter & Gamble Manufactura S. de R.L. de C.V.

    FDA warned P&G Manufactura over mismatched active ingredients in the drug listing for Vicks Nyquil Severe Hot Remedy.

    Low
  4. Grimann S.A. de C.V.

    FDA warns Grimann over Derofen Miel drug listing with contradictory active ingredients, label image, and package size.

    Low
  5. ECI Pharmaceuticals, LLC

    FDA warned ECI Pharmaceuticals for listing the wrong active ingredient for its estrogen and testosterone drugs, which got them removed from the NDC Directory.

    Low
  6. RPK Pharmaceuticals Inc.

    RPK Pharmaceuticals sent FDA a mismatched label for clotrimazole and betamethasone dipropionate cream in its drug listing.

    Low